Tempest Therapeutics Inc. Common Stock (TPST)
Stock · NASDAQ · Health Care
$0.624as of 10/16/2026
Price chart
Active signals
TPST Signal Track Record
How signals performed across all stocks →What TPST's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 29 | -5.1% | 28% | September 10, 2026 |
| Bollinger Band Breakdown | 26 | -8.3% | 31% | September 9, 2026 |
| Bollinger Band Breakout | 12 | -16.6% | 33% | August 11, 2026 |
| 200-Day Moving Average TouchActive now | 4 | +8.5% | 75% | November 4, 2025 |
| Any 20-session window (baseline) | -9.7% | 29% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About TPST
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 4
- Website
- www.tempesttx.com/
Fundamentals
- 1-day range
- $0.644$0.6964
- Market cap
- $14.42M
- P/E (trailing)
- —
- P/E (forward)
- -0.54
- EPS (trailing)
- $-4.49
- Dividend yield
- —
- Beta
- -1.63
- Avg. volume
- 2.59M
- Dividend pay date
- December 10, 2018
How Tempest Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2017 annual results
Source: 10-K filed Mar 15, 2018 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Tempest Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TPSTTempest Therapeutics Inc. Common Stock$0.624▼ 1.73%Market cap $14.42MP/E —$0.6801$12.23
- KALAKALA BIO Inc. Common Stock$0.19▼ 1.04%Market cap $14.25MP/E —$0.2593$95.5
- COCPCocrystal Pharma Inc. Common Stock$1.02▼ 0.97%Market cap $14.20MP/E —$0.76$2.03
- AKTXAkari Therapeutics plc ADS$8.18▼ 7.47%Market cap $14.14MP/E Infinity$3.02$39.64
- KTTAPasithea Therapeutics Corp. Common Stock$0.42▲ 2.44%Market cap $14.82MP/E —$0.281$2.06
- PTNPalatin Technologies Inc. Common Stock$6.02▼ 7.24%Market cap $14.00MP/E 92.55$5.61$31
- HINDVyome Holdings Inc. Common Stock$1.87▼ 2.09%Market cap $15.02MP/E —$1.75$6.56
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TPST Tempest Therapeutics Inc. Common Stock | $14.42M | — | $0.624 | ▼ 1.73% | $0.6801$12.23 |
| KALA KALA BIO Inc. Common Stock | $14.25M | — | $0.19 | ▼ 1.04% | $0.2593$95.5 |
| COCP Cocrystal Pharma Inc. Common Stock | $14.20M | — | $1.02 | ▼ 0.97% | $0.76$2.03 |
| AKTX Akari Therapeutics plc ADS | $14.14M | Infinity | $8.18 | ▼ 7.47% | $3.02$39.64 |
| KTTA Pasithea Therapeutics Corp. Common Stock | $14.82M | — | $0.42 | ▲ 2.44% | $0.281$2.06 |
| PTN Palatin Technologies Inc. Common Stock | $14.00M | 92.55 | $6.02 | ▼ 7.24% | $5.61$31 |
| HIND Vyome Holdings Inc. Common Stock | $15.02M | — | $1.87 | ▼ 2.09% | $1.75$6.56 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Unusual volume stocks in Friday's sessionChartMill · 9/18/2026
- Top movers in Thursday's sessionChartMill · 9/17/2026
- Which stocks have an unusual volume on Thursday?ChartMill · 9/17/2026
- Here are the top movers in Thursday's session.ChartMill · 9/17/2026
- Let's uncover which stocks are experiencing notable gaps during today's session.ChartMill · 9/17/2026
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 9/17/2026
- These stocks are moving in today's pre-market sessionChartMill · 9/17/2026
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 9/17/2026
Insider Activity
Insider Actions →- Richey William Drake · June 4, 2026 · Grant25.0K
- Yee John D. · June 4, 2026 · Grant25.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 448.1K
- Total value held
- $734.8K
- Institutional holders
- 18
- Unknown233.9K
- Unknown87.0K
- Unknown39.1K
- Unknown33.2K
- Unknown17.9K
- Unknown14.1K
- Unknown11.4K
- Unknown4.5K
- Unknown2.8K
- Unknown2.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
TPST Files Prospectus to Register Resale of Up to 9.5M Shares
Tempest Therapeutics has filed a prospectus to register the resale of up to 9,534,164 shares of common stock. This filing allows the company to offer more shares to the public, potentially increasing the available supply. The move is a routine corporate action that may influence the stock’s liquidity and market perception.
TPST Files Prospectus to Register Resale of Up to 9.5M Shares. Tempest Therapeutics has filed a prospectus to register the resale of up to 9,534,164 shares of common stock. This filing allows the company to offer more shares to the public, potentially increasing the available supply. The move is a routine corporate action that may influence the stock’s liquidity and market perception.